Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 582
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03874754 | Tailored Home-Based Exercise Program for Multiple Chronic Conditions | ||
| NCT02644291 | Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors | ||
| NCT01896869 | FOLFIRINOX Followed by Ipilimumab With Pancreatic Tumor Vaccine in Treatment of Metastatic Pancreatic Cancer | ||
| NCT06205836 | Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer | ||
| NCT03535675 | Muscadine Plus (MPX) In Men With Prostate Cancer | ||
| NCT03965494 | AXL Inhibitor BGB324 in Treating Participants With Recurrent Glioblastoma Undergoing Surgery | ||
| NCT01431794 | Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma | ||
| NCT01135329 | Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers | ||
| NCT00631137 | Testosterone Gel in Preventing Weakness Caused by Steroid Therapy in Men With Glioma | ||
| NCT00281866 | Erlotinib in Treating Patients With Metastatic and/or Recurrent Head and Neck Cancer | ||
| NCT01763970 | Stereotactic Radiation Therapy for Pediatric Sarcomas | ||
| NCT01763931 | DIG-HIF-1 Pharmacodynamic Trial in Newly Diagnosed Operable Breast Cancer | ||
| NCT02396368 | A Study of Radium-223 in Combination With Tasquinimod in Bone-only Metastatic Castration-Resistant Prostate Cancer | ||
| NCT03607890 | Study of Nivolumab and Relatlimab in Advanced Mismatch Repair Deficient Cancers Resistant to Prior PD-(L)1 Inhibitor | ||
| NCT00007813 | Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors | ||
| NCT01045460 | Trial of Activated Marrow Infiltrating Lymphocytes Alone or in Conjunction With an Allogeneic Granulocyte Macrophage Colony-stimulating Factor (GM-CSF)-Based Myeloma Cellular Vaccine in the Autologous Transplant Setting in Multiple Myeloma | ||
| NCT02923180 | Neoadjuvant Enoblituzumab (MGA271) in Men With Localized Intermediate and High-Risk Prostate Cancer | ||
| NCT00882583 | A Study of Dasatinib, Cetuximab and Radiation With or Without Cisplatin in HNSCC | ||
| NCT02574546 | Markers for Predicting Risk of Breast Cancer in Women of Different Races | ||
| NCT03786796 | Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations | ||
| NCT03914742 | BGB-290 and Temozolomide in Treating Patients With Recurrent Gliomas With IDH1/2 Mutations | ||
| NCT03843814 | Pilot Study Using Amide Proton Transfer Magnetic Resonance Imaging Distinguishing Glioma | ||
| NCT00006239 | Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer | ||
| NCT00416312 | Iodine I 131 Tositumomab or Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma | ||
| NCT00052715 | Biological Therapy and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | ||
| NCT00539318 | Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers | ||
| NCT00363649 | Interferon and GM-CSF Compared With Imatinib Mesylate and Vaccine Therapy in Patients With Chronic Phase CML on a TKI | ||
| NCT02389738 | Brain Interstitium Temozolomide Concentration Pre and Post Regadenoson Administration | ||
| NCT03497377 | Evaluation of 18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer. | ||
| NCT00005639 | Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment | ||
| NCT00539656 | Transplantation of Umbilical Cord Blood Following Chemotherapy for Blood Cancers | ||
| NCT03507608 | Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression | ||
| NCT00276588 | Gemcitabine and Carboplatin Followed by Paclitaxel in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | ||
| NCT00486603 | Hydroxychloroquine, Radiation, and Temozolomide Treating Patients With Newly Diagnosed Glioblastoma Multiforme | ||
| NCT04116073 | INCMGA00012 in Patients With Previously Treated Unresectable or Metastatic Adenosquamous Pancreatic or Ampullary Cancer | ||
| NCT03161379 | GVAX Pancreas Vaccine (With CY) in Combination With Nivolumab and SBRT for Patients With Borderline Resectable Pancreatic Cancer | ||
| NCT00293280 | Lomustine in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | ||
| NCT00465673 | Liposomal Doxorubicin (Lipo-Dox) in Patients With Brain Metastasis From Breast Cancer | ||
| NCT04266431 | EMPOWER Men to Reduce Weight and Inhibit Prostate Cancer Progression | ||
| NCT00499486 | Sirolimus in Treating Patients With Advanced Pancreatic Cancer | ||
| NCT01088802 | Treatment De-Intensification for Squamous Cell Carcinoma of the Oropharynx | ||
| NCT01728779 | Stereotactic Body Radiation With Nelfinavir for Oligometastases | ||
| NCT04019964 | Nivolumab in Biochemically Recurrent dMMR Prostate Cancer | ||
| NCT02981524 | Study of GVAX (With CY) and Pembrolizumab in MMR-p Advanced Colorectal Cancer | ||
| NCT03091478 | Pembrolizumab in Patients With Leptomeningeal Disease | ||
| NCT00364078 | Transitoriness in Cancer Patients, Psychosocial Issues in Cancer Care | ||
| NCT05014776 | Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic Cancer | ||
| NCT00249847 | Study of PET Scans and Serotonin in Hot Flashes Treatment | ||
| NCT03800784 | Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer | ||
| NCT02845323 | Neoadjuvant Nivolumab With and Without Urelumab in Cisplatin-Ineligible or Chemotherapy-refusing Patients With Muscle-Invasive Urothelial Carcinoma of the Bladder |
